Bottom line
How much do PBE and GNOM overlap?
22% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 25.0% of PBE's assets and 25.4% of GNOM's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings PBE and GNOM have in common
| Holding | % of PBE | % of GNOM | Overlap |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 4.99% | 3.95% | 3.95% |
| Gilead Sciences, Inc. | 4.43% | 1.95% | 1.95% |
| Bio-Techne Corp. | 3.73% | 3.41% | 3.41% |
| Illumina, Inc. | 3.51% | 4.82% | 3.51% |
| Qiagen N.V. | 2.89% | 3.54% | 2.89% |
| BioMarin Pharmaceutical Inc. | 2.82% | 4.09% | 2.82% |
| Veracyte, Inc. | 2.60% | 3.64% | 2.60% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PBE
- Invesco Private Prime Fund — 12.89%
- Regeneron Pharmaceuticals, Inc. — 5.47%
- Amgen Inc. — 5.22%
- CareDx, Inc. — 5.04%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Biogen Inc. — 4.79%
- United Therapeutics Corp. — 4.08%
- Protagonist Therapeutics, Inc. — 3.40%
- Vericel Corp. — 3.27%
- Alnylam Pharmaceuticals, Inc. — 3.17%
- Incyte Corp. — 3.06%
- Repligen Corp. — 3.04%
- Acadia Pharmaceuticals Inc. — 3.02%
- Halozyme Therapeutics, Inc. — 2.98%
Only in GNOM
- Guardant Health, Inc. — 5.59%
- Natera, Inc. — 4.15%
- Arrowhead Pharmaceuticals, Inc. — 4.07%
- Legend Biotech Corp — 4.05%
- Praxis Precision Medicines Inc — 4.01%
- Twist Bioscience Corp — 3.97%
- CRISPR Therapeutics AG — 3.85%
- BioNTech SE — 3.41%
- Moderna, Inc. — 3.28%
- 10X Genomics Inc — 3.23%
- Beam Therapeutics Inc — 3.09%
- Bnyrepos — 3.05%
- Eli Lilly And Company — 2.32%
- Ultragenyx Pharmaceutical Inc — 2.25%
- Caris Life Sciences, Inc. — 2.03%
Asset mix
| Asset type | PBE | GNOM |
|---|---|---|
| Stocks | 100.1% | 99.9% |
| Cash & short-term funds | 17.9% | — |
| Repurchase agreements | — | 3.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Country mix
| Country | PBE | GNOM |
|---|---|---|
| US | 108.6% | 99.1% |
| GB | 4.9% | 1.8% |
| NL | 2.9% | — |
| HK | — | 2.0% |
| KY | 1.6% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do PBE and GNOM overlap?
What stocks do PBE and GNOM have in common?
Should I own both PBE and GNOM?
Which holds more stocks, PBE or GNOM?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.